Two new studies that have been published recently show that people who have been taking weight loss drugs may have encountered an increased risk of serious eye conditions and vision loss.

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

Researchers uncover ‘dangerous’ threat of global scam operation affecting millions as health regulators warn fraudulent ...

The morbidly obese members of the so-called National Association to Advance Fat Acceptance (NAAFA) have predictably come out ...

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that obesity is a problem at all.

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...

GLP-1 drugs often cause weight loss because they mimic the GLP-1 hormone the body naturally produces after eating. Appetite decreases as users feel fuller for longer. The meds are prescribed to people ...

Could popular diabetes and weight loss drugs like Ozempic actually protect your brain from stroke damage, or prevent strokes altogether? Three new studies presented at a major neurosurgery conference ...